Pardes Biosciences Inc (PRDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-1999 | |
| Assets | |
| Current Assets | |
| Other current assets | 2,210 |
| TOTAL | $2,210 |
| Non-Current Assets | |
| PPE Net | 2,380 |
| Other Non-Current Assets | 4,410 |
| TOTAL | $6,790 |
| Total Assets | $9,000 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 5,100 |
| Other current liabilities | 170 |
| TOTAL | $5,590 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 5 |
| TOTAL | $485 |
| Total Liabilities | $6,075 |
| Shareholders' Equity | |
| Common Shares | 10 |
| Other shareholders' equity | -600 |
| TOTAL | $32,820 |
| Total Liabilities And Equity | $38,895 |